|Association between residual symptoms domains, pain and functioning|
|Odds Ratio||95% Wald Confidence Limits|
|Gender (male vs. female)||1.356||0.886||2.076|
|Academic degree (high vs. other)||1.580||0.949||2.629|
|Baseline functioning level (SOFAS)||1.049||1.031||1.067|
|Episode length (4–24 weeks vs. ≥ 24 weeks)||2.008||1.127||3.579|
|Episode lenght (≤4 weeks vs. ≥24 weeks)||2.138||1.145||3.992|
|Absence of residual core mood symptoms||8.728||4.553||16.730|
|Absence of residual insomnia symptoms||1.796||1.175||2.744|
|Absence of residual anxiety symptoms and absence of pain||5.257||2.445||11.300|
|Absence of residual anxiety symptoms and presence of pain||0.412||0.073||2.341|
|Absence of pain and absence of residual anxiety symptoms||21.669||3.544||132.498|
|Absence of pain and presence of residual anxiety symptoms||1.700||1.025||2.819|
Logistic regression model.
SOFAS = Social and Occupational Functioning Assessment Scale;
Dependent variable: normal level of functioning (SOFAS total score ≥80) after 3 months of antidepressant treatment.
Romera et al.
Romera et al. BMC Psychiatry 2013 13:51 doi:10.1186/1471-244X-13-51